– Twenty patients with indolent (n=18) and aggressive (n=2) R/R B-NHL received evorpacept plus standard rituximab and lenalidomide (“R2”)– Evorpacept plus […]
VANCOUVER, British Columbia, April 09, 2024 (GLOBE NEWSWIRE) — Eldorado Gold Corporation (“Eldorado” or the “Company”) today provides the following […]